While Exelon's recent earnings beat expectations, the utility giant continues to face investor skepticism over its long-term growth trajectory. Wall Street maintains a guarded optimism, but the stock's performance tells a more nuanced story.
The restaurant chain Steak 'n Shake has announced it will contribute $1,000 to tax-advantaged investment accounts for employees' newborns, aligning with a growing corporate trend to supplement the federal 'Trump Accounts' program aimed at generational wealth building.
Panama's Supreme Court has annulled the long-term concession of Hong Kong-based CK Hutchison to operate key ports at the Panama Canal, appointing Denmark's Maersk as temporary administrator. The move follows geopolitical tensions and allegations of unpaid fees.
Facing what CEO Peter Vanacker calls the 'deepest and longest downturn' of his career, LyondellBasell reported Q1 2025 results while detailing a new $500 million cash improvement plan. The chemical giant is leaning into portfolio restructuring and its global supply network to weather trade policy uncertainty and weak demand.
President Trump nominates Kevin Warsh, a former Fed governor with Wall Street ties, to succeed Jerome Powell as Federal Reserve Chair. His confirmation faces scrutiny amid questions over monetary policy direction and the central bank's political independence.
Beazer Homes USA reported a steeper-than-expected quarterly loss, with revenue falling 22% amid a challenging housing market characterized by soft demand and aggressive competitor pricing.
With Bitcoin consolidating below $90,000, a significant retreat from its October highs, investors are weighing whether this is a strategic entry point or a warning sign. We examine the competing narratives shaping the market's next move.
Elon Musk is reportedly in discussions to merge his aerospace giant SpaceX with his artificial intelligence venture xAI, aiming to create an integrated powerhouse for deploying AI data centers in orbit, powered by space solar energy.
Despite posting a Q4 net loss, ArcBest is streamlining operations and investing in technology, positioning for a market rebound while the broader LTL sector continues its slow climb from a prolonged slump.
An unexpected jump in the Producer Price Index for December underscores the stubborn nature of inflation, with rising wholesale costs threatening to ripple through the economy and sustain higher prices for households.
Congress has approved $23 billion in initial funding for the ambitious Golden Dome missile defense initiative, yet the absence of a detailed spending blueprint from the Pentagon is stalling progress and clouding investment prospects for 2026.
Pharmaceutical leader Eli Lilly will build a new manufacturing facility in Lehigh County, marking the largest life sciences investment in Pennsylvania history and bolstering U.S. production of next-generation weight-loss drugs.
From post-IPO darling to a stock trading near historic lows, Rivian faces a critical five-year window. With new models on the horizon and a major Volkswagen partnership, analysts see a path to growth—if it can navigate fierce competition and persistent losses.
St. Louis Fed President Alberto Musalem argues the current interest rate stance is appropriate, signaling a pause in the central bank's easing cycle unless the labor market weakens or inflation drops unexpectedly.
A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.
President Trump's nomination of Kevin Warsh, a known monetary policy hawk, to lead the Federal Reserve sent initial shockwaves through equities and bonds on Friday, raising questions about the future path of interest rates.
American Express reported fourth-quarter earnings that narrowly missed analyst forecasts, yet a modest stock decline reflects investor confidence in its robust guidance and the sustained momentum of its high-end cardmember base.
Eli Lilly announces a massive new manufacturing facility in Pennsylvania, part of a strategic pivot by major drugmakers to onshore production amid trade tensions and soaring demand for weight-loss drugs.
Despite lagging the broader market over the past year, Ingersoll Rand shows signs of a strategic pivot. Wall Street sees modest upside potential as the industrial giant navigates headwinds and pursues growth through acquisition.
BlackRock has increased its stake in the diversified precious metals miner Sibanye-Stillwater beyond 5%, signaling strong institutional confidence amid a historic rally in gold and platinum group metals. We examine the drivers behind the surge and what it means for investors.
